![]() Chengdu Push Bio-technology Chengdu Push Bio-technology (成都普思生物科技股份有限公司) is a provider of separation and purification of natural medicines and pharmaceutical research services. | ![]() Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. | ![]() Hutchison China Meditech Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products. | |
Founding Date | Founding Date 2005 | Founding Date 1849 | Founding Date 2000 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Cheng Du Shi, CN HQ | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Shanghai, CN HQ Beijing, CN Jiangsu, CN Shanghai, CN Shanghai, CN Hong Kong, HK Hong Kong, HK see more |
Employees | Employees N/A | Employees 81,0008% decrease | Employees 1,811 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) 3.6 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $548.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $16.1b (FY, 2025) | Cost of goods $324.4m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $46.5b (FY, 2025) | Gross profit $224.2m (FY, 2025) |
Net income | Net income N/A | Net income $7.8b (FY, 2025) | Net income $435.1m (FY, 2025) |

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View company
Hutchison China MediTech is a biopharmaceutical company, engaging in the research, development, manufacture and sale of pharmaceuticals and healthcare products.
View company